Biotech

All Articles

' All hands on deck' at Lilly as peers target obesity market

.Chief executive officer David Ricks may observe the firms putting together tents at basecamp behind...

Entero laying off team, moving out of workplace and also stopping R&ampD

.Cushion Liquidators has transformed Entero Rehabs white colored as a piece. The creditor ordered En...

Exelixis falls ADC after choosing it's no match for Tivdak

.Exelixis is losing hope on its own tissue variable (TF)- targeting antibody-drug conjugate after wr...

Relay loses interest in SHP2 prevention after Genentech leaves

.Three weeks after Roche's Genentech unit ignored an SHP2 inhibitor pact, Relay Rehab has validated ...

Stoke's Dravet syndrome med launched of predisposed medical grip

.Stoke Rehabs' Dravet disorder medication has been without a partial hold, getting rid of the means ...

Fierce Biotech's Gabrielle Masson presents Brutal 15 at NYSE

.Intense Biotech Colleague Publisher Gabrielle Masson offered the 2024 class of Brutal 15 winners on...

Daiichi spends Merck $170M to develop bronchi cancer cells T-cell engager deal

.Merck &amp Co. has promptly made back a few of the expenses of its Weapon Therapeutics purchase, pu...

BioMarin stops preclinical gene treatment for heart condition

.After BioMarin conducted a springtime tidy of its pipeline in April, the company has chosen that it...

Eisai plants molecular adhesive SEED along with $1.5 B biobucks work

.Large Pharmas remain stuck to the tip of molecular adhesive degraders. The current company to see a...

Life scientific research debt firm unveils with $600M

.A brand new global lifestyle science credit rating firm, nicknamed Symbiotic Capital, has brought u...